,8 Besides, a meta-analysis indicated radiotherapy benefit extent is associated with patient age, tumor grade, estrogen receptor (ER) status, and endocrine treatment, with younger patients and high-grade tumor cases benefiting more.9 The gene discussed is ESR1; the disease is neoplasm.